ConductScience.org, home

Paper15768339

Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users.

Strathdee SA and 10 others. Clin Infect Dis, 2005. Cited by 93 papers, by iCite.

Cite this record

ConductScience Library. Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users. Papers, record 15768339. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15768339

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users.
PubMed
Journal
Clin Infect Dis
PubMed
Year
2005
PubMed
Publication types
Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
2.57
iCite
Revised in PubMed
2025-05-29
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Strathdee SASteffanie A
2Latka MM
3Campbell JJ
4O'Driscoll PTP T
5Golub ETE T
6Kapadia FF
7Pollini RAR A
8Garfein RSR S
9Thomas DLD L
10Hagan HH
11Study to Reduce Intravenous Exposures ProjectGroup

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis CMajor topic
Substance Abuse, IntravenousMajor topic
Adolescent
Adult
Age Factors
Baltimore
Cross-Sectional Studies
Female
Humans
Male
Multivariate Analysis
New York City
Patient Selection
Physician-Patient Relations
Sex Factors
Washington

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 DA014499NIDA NIH HHSUnited StatesR01DA014499PubMed and NIH
DA-14499NIDA NIH HHSUnited StatesR01DA014499PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00391482Study to Reduce Intravenous Exposures (STRIVE)Background

Source ClinicalTrials.gov

Download CSV of trials

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18329970Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.Addiction1993https://conductscience.org/library/papers/8329970PubMed
212095661Treating hepatitis C in methadone maintenance patients: an interim analysis.Drug Alcohol Depend2002https://conductscience.org/library/papers/12095661PubMed
312491208Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment.Clin Infect Dis2003https://conductscience.org/library/papers/12491208PubMed
411599327Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.CMAJ2001https://conductscience.org/library/papers/11599327PubMed
514631267[Perception of hepatitis C infection and its management in women infected by HIV following intravenous use of drugs].Presse Med2003https://conductscience.org/library/papers/14631267PubMed
614572580Response to treatment of hepatitis C in individuals with a recent history of intravenous drug abuse.Am J Gastroenterol2003https://conductscience.org/library/papers/14572580PubMed
77587974Stages and processes of change among polydrug users in methadone maintenance treatment.Drug Alcohol Depend1995https://conductscience.org/library/papers/7587974PubMed
89707146Barriers to use of free antiretroviral therapy in injection drug users.JAMA1998https://conductscience.org/library/papers/9707146PubMed
912684917Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection.Clin Infect Dis2003https://conductscience.org/library/papers/12684917PubMed
109722817Facilitating treatment entry among out-of-treatment injection drug users.Public Health Rep1998https://conductscience.org/library/papers/9722817PubMed
1110888972Screening for alcohol problems in primary care: a systematic review.Arch Intern Med2000https://conductscience.org/library/papers/10888972PubMed
1211583749Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.Lancet2001https://conductscience.org/library/papers/11583749PubMed
1312627745Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men.AIDS Educ Prev2003https://conductscience.org/library/papers/12627745PubMed
1412407596Prevention and treatment of hepatitis C in injection drug users.Hepatology2002https://conductscience.org/library/papers/12407596PubMed
151329589In search of how people change. Applications to addictive behaviors.Am Psychol1992https://conductscience.org/library/papers/1329589PubMed
1612650800Identification and management of hepatitis C patients in primary care clinics.Am J Gastroenterol2003https://conductscience.org/library/papers/12650800PubMed
1711164684Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment.Drug Alcohol Depend2001https://conductscience.org/library/papers/11164684PubMed
1811978211Diagnosis and 10-year follow-up of a community-based hepatitis C cohort.J Fam Pract2002https://conductscience.org/library/papers/11978211PubMed
1911463019Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?N Engl J Med2001https://conductscience.org/library/papers/11463019PubMed
208905229Dual diagnosis: a treatment model for substance abuse and major mental illness.Community Ment Health J1996https://conductscience.org/library/papers/8905229PubMed

See all 35 referencesDownload CSV of references

Cited by50

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
38464492Barriers to Hepatitis C Treatment and Interest in Telemedicine-Based Care Among Clients of a Syringe Access Program.Open Forum Infect Dis2024https://conductscience.org/library/papers/38464492PubMed
38301921Prevalence and associated risk factors of hepatitis C antibody and RNA among people who inject drugs in Puerto Rico.J Subst Use Addict Treat2024https://conductscience.org/library/papers/38301921PubMed
37285080Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study.Adv Ther2023https://conductscience.org/library/papers/37285080PubMed
33667826High HCV cure rates among people who inject drugs and have suboptimal adherence: A patient-centered approach to HCV models of care.Int J Drug Policy2021https://conductscience.org/library/papers/33667826PubMed
31816111
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
Hepatology2020https://conductscience.org/library/papers/31816111PubMed
31087764Integrated care for methadone maintenance patients with hepatitis C virus infection.Kaohsiung J Med Sci2019https://conductscience.org/library/papers/31087764PubMed
30959528Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial.Ann Intern Med2019https://conductscience.org/library/papers/30959528PubMed
30613166Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder.Hepat Med2019https://conductscience.org/library/papers/30613166PubMed
30255113Hepatitis C Within a Single Health System: Progression Along the Cascade to Cure Is Higher for Those With Substance Misuse When Linked to a Clinic With Embedded Support Services.Open Forum Infect Dis2018https://conductscience.org/library/papers/30255113PubMed
30035835Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs.Addiction2019https://conductscience.org/library/papers/30035835PubMed
29949450Hepatitis C cascade of care among people who inject drugs in Vancouver, Canada.Subst Abus2018https://conductscience.org/library/papers/29949450PubMed
29568730Factors associated with tobacco, alcohol, and other drug use among youth living in West Central Mexico.World J Psychiatry2018https://conductscience.org/library/papers/29568730PubMed
29426304Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy.BMC Infect Dis2018https://conductscience.org/library/papers/29426304PubMed
29020317Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings.Clin Infect Dis2018https://conductscience.org/library/papers/29020317PubMed
28962652Perceived benefits of the hepatitis C peer educators: a qualitative investigation.Harm Reduct J2017https://conductscience.org/library/papers/28962652PubMed
28785531Hepatitis C: Review of the Epidemiology, Clinical Care, and Continued Challenges in the Direct Acting Antiviral Era.Curr Epidemiol Rep2017https://conductscience.org/library/papers/28785531PubMed
28721344Exploring Patient Characteristics and Barriers to Hepatitis C Treatment in Patients on Opioid Substitution Treatment Attending a Community Based Fibro-scanning Clinic.J Transl Int Med2017https://conductscience.org/library/papers/28721344PubMed
28648353Healthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs.Int J Drug Policy2017https://conductscience.org/library/papers/28648353PubMed
28615023Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study.Int J Equity Health2017https://conductscience.org/library/papers/28615023PubMed
28294492High prevalence of willingness to use direct-acting antiviral-based regimens for hepatitis C virus (HCV) infection among HIV/HCV coinfected people who use drugs.HIV Med2017https://conductscience.org/library/papers/28294492PubMed

See all 50 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15768339

GET https://conductscience.org/api/papers/v1/15768339/references?page=2